Eric joined Horizon Pharma in October 2016 as part of the Raptor Pharmaceutical Corp. acquisition. He has 15 years of experience in the healthcare industry, with the majority of his tenure focused on launching and commercializing treatments for rare diseases. Prior to joining Horizon, Eric was senior vice president, Americas and Asia Pacific at Raptor, where he led the U.S. launch of PROCYSBI®. Prior to Raptor, Eric served as the lead for commercial operations and market access at Enobia Pharma, Inc. He also served in increasing leadership roles for commercial operations at Onyx Pharmaceuticals, Jazz Pharmaceuticals Inc., Chiron Corporation and Millennium Pharmaceuticals. Eric also has extensive experience in management, healthcare and technology consulting through positions at IBM, Teltech Resource Network Corporation, and Kohler Company. Eric joined Horizon Pharma in October 2016 as part of the Raptor Pharmaceutical Corp. acquisition. He has 15 years of experience in the healthcare industry, with the majority of his tenure focused on launching and commercializing treatments for rare diseases. Prior to joining Horizon, Eric was senior vice president, Americas and Asia Pacific at Raptor, where he led the U.S. launch of PROCYSBI®. Prior to Raptor, Eric served as the lead for commercial operations and market access at Enobia Pharma, Inc. He also served in increasing leadership roles for commercial operations at Onyx Pharmaceuticals, Jazz Pharmaceuticals Inc., Chiron Corporation and Millennium Pharmaceuticals. Eric also has extensive experience in management, healthcare and technology consulting through positions at IBM, Teltech Resource Network Corporation, and Kohler Company.

General Science